Actual Medicinal Product (AMP) Daxas 500microgram tablets (Mawdsley-Brooks & Company Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Daxas 500microgram tablets (AstraZeneca UK Ltd).

Generic
Roflumilast
Formulation
Roflumilast 500microgram tablets
  • Roflumilast
    • Roflumilast 500microgram tablets

      • Daxas 500microgram tablets (Mawdsley-Brooks & Company Ltd)